{"id":7374,"date":"2021-09-30T06:54:54","date_gmt":"2021-09-30T06:54:54","guid":{"rendered":"https:\/\/cn.quancapital.com\/?page_id=7374"},"modified":"2025-11-17T08:26:35","modified_gmt":"2025-11-17T08:26:35","slug":"yingying-yang","status":"publish","type":"page","link":"https:\/\/cn.quancapital.com\/en\/about\/yingying-yang\/","title":{"rendered":"Yingying Yang"},"content":{"rendered":"<p>[vc_row content_width=&#8221;grid&#8221; css=&#8221;.vc_custom_1516178292324{padding-top: 80px !important;padding-bottom: 80px !important;}&#8221;][vc_column offset=&#8221;vc_col-lg-5 vc_col-md-12&#8243;][vc_single_image image=&#8221;7375&#8243; img_size=&#8221;full&#8221;][\/vc_column][vc_column offset=&#8221;vc_col-lg-7 vc_col-md-12&#8243; css=&#8221;.vc_custom_1516178311504{padding-right: 50px !important;padding-left: 50px !important;}&#8221;][vc_column_text]Ms. Yingying Yang is a Partner of Quan Capital based at the firm\u2019s Shanghai office. \u00a0Prior to joining Quan in 2017, Ms. Yang was with Sanofi China\u2019s strategy planning group, focusing on internal pipeline prioritization and external licensing \/ M&amp;A strategy. \u00a0Before Sanofi, she served as associate consultant at LEK consulting, focusing on healthcare and particularly pharmaceutical sector.<\/p>\n<p>&nbsp;<\/p>\n<p>Ms. Yang received her Bachelor in Economics from Fudan University, and a MSc of Finance from Imperial College London. \u00a0She also obtained a dual Bachelor degree in Pharmacology from Shanghai Jiaotong University, School of Medicine when she\u2019s at Quan.<\/p>\n<p>&nbsp;<\/p>\n<p>Ms. Yang currently serves on the board of Oricell Therapeutics. She also serves as a board observer of Eluminex Biosciences, RareStone Group, MEDx, and deeply involved in Quan\u2019s investments of Avenzo Therapeutics and Windward Bio. She was a board member of Kira Pharmaceuticals and a board observer of Innoforce.[\/vc_column_text][vc_empty_space height=&#8221;25px&#8221;][\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>[vc_row content_width=&#8221;grid&#8221; css=&#8221;.vc_custom_1516178292324{padding-top: 80px !important;padding-bottom: 80px !important;}&#8221;][vc_column offset=&#8221;vc_col-lg-5 vc_col-md-12&#8243;][vc_single_image image=&#8221;7375&#8243; img_size=&#8221;full&#8221;][\/vc_column][vc_column offset=&#8221;vc_col-lg-7 vc_col-md-12&#8243; css=&#8221;.vc_custom_1516178311504{padding-right: 50px !important;padding-left: 50px !important;}&#8221;][vc_column_text]Ms. Yingying Yang is&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":6552,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"full-width.php","meta":{"footnotes":""},"_links":{"self":[{"href":"https:\/\/cn.quancapital.com\/en\/wp-json\/wp\/v2\/pages\/7374"}],"collection":[{"href":"https:\/\/cn.quancapital.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/cn.quancapital.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/cn.quancapital.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/cn.quancapital.com\/en\/wp-json\/wp\/v2\/comments?post=7374"}],"version-history":[{"count":5,"href":"https:\/\/cn.quancapital.com\/en\/wp-json\/wp\/v2\/pages\/7374\/revisions"}],"predecessor-version":[{"id":8413,"href":"https:\/\/cn.quancapital.com\/en\/wp-json\/wp\/v2\/pages\/7374\/revisions\/8413"}],"up":[{"embeddable":true,"href":"https:\/\/cn.quancapital.com\/en\/wp-json\/wp\/v2\/pages\/6552"}],"wp:attachment":[{"href":"https:\/\/cn.quancapital.com\/en\/wp-json\/wp\/v2\/media?parent=7374"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}